null

Blog

TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program

TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program

PRESS RELEASE TruWay Health Announces OMNIPHYS: A 20-Year Multimodal Physiologic State Intelligence Research Program For Immediate ReleaseSeptember 2, 2026TruWay Health — News & Insights New prospective observational platform will investigate longitudinal physiologic trajectories using multimodal ultrasound, artificial intelligence, and privacy-preserving federated learning NEW YORK — September 2, 2026 — TruWay Health today announced the formal release of TH-OMNIPHYS-20 …
Sep 2nd 2026 Truway Health
Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health

Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health

PRESS RELEASE Truway Health Announces ClinicalTrials.gov Registration of 50-Year Prospective Study Examining “Clinical Time” and Temporal Dynamics in Patient Health NEW YORK — September 1, 2026 — Truway Health today announced the release of its prospective observational research protocol, TH-CLINICAL-TIME-2026-001, titled “Clinical Time and Temporal Dynamics Study (CLINICAL-TIME)”, establishing a long-term research framework to investigate how changes …
Sep 1st 2026 Truway Health
TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration

TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration

TruWay Health Advances FUSION-72 Study to Investigate Multimodal Digital Biomarkers for Acute Deterioration News & Insights | September 1, 2026 TruWay Health is advancing FUSION-72: Multimodal Digital Biomarker Prediction of Acute Deterioration, a research initiative conducted under TH-FUSION72-2026-001. The study is focused on an emerging area of clinical research: understanding whether combinations of digital biomarkers and longitudinal clinical signals can help identify patterns associate …
Sep 1st 2026 Truway Health
Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study

Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study

FOR IMMEDIATE RELEASE Truway Health Releases TRU-OMNIBODY Whole-Body Digital Twin and Physiologic Resilience Study Prospective observational study will evaluate whether a locked computational model can characterize and predict multisystem recovery in approximately 450 adults NEW YORK — September 1, 2026 — Truway Health, Inc. today announced that the protocol record for the Truway Whole-Body Digital Twin and Physiologic Resilience Study, known as TRU-OMNIBODY, has been released throug …
Aug 31st 2026 Truway Health
Choosing Surgical Loupes: 2.5× vs. 3.5× Magnification

Choosing Surgical Loupes: 2.5× vs. 3.5× Magnification

Surgical loupes provide a magnified view of the working area, helping healthcare professionals see fine anatomical details while maintaining a more comfortable working posture. Two of the most common magnification options are 2.5× and 3.5×, but the right choice depends on the procedure, experience level, working distance, and desired field of view. The Quick Answer Choose 2.5× surgical loupes if you want a wider field of view, greater depth of field, easier adaptation, and an a …
Aug 31st 2026 Truway Health
Truway Health Releases TVA-2026 Clinical Study Evaluating Ultrasound-Guided Peripheral Vascular Access

Truway Health Releases TVA-2026 Clinical Study Evaluating Ultrasound-Guided Peripheral Vascular Access

FOR IMMEDIATE RELEASE Truway Health Releases TVA-2026 Clinical Study Evaluating Ultrasound-Guided Peripheral Vascular Access Prospective randomized study will compare ultrasound-guided vascular access with standard peripheral cannulation techniques, with first-attempt cannulation success as the primary outcome NEW YORK — August 24, 2026 — Truway Health, Inc. today announced that its new clinical research protocol, TruVascular Access – Ultrasound-Guided Vascular Access Study (TV …
Aug 24th 2026 Truway Health Clinical Research
When Public Health Meets Institutional Accountability: Why Evidence, Transparency, and Ethics Still Matter

When Public Health Meets Institutional Accountability: Why Evidence, Transparency, and Ethics Still Matter

Public health depends on trust. But trust is not created by slogans, authority, corporate branding, or repetition. It is earned through accurate information, transparent evidence, meaningful informed consent, responsible correction of mistakes, and institutional accountability. The COVID-19 pandemic placed pharmaceutical manufacturers, government agencies, healthcare organizations, employers, universities, and media institutions under extraordinary pressure. Decisions were made quickly, evidence …
Aug 15th 2026 Truway Health
Medical Equipment Acceptance Testing: What Happens Before Final Handover

Medical Equipment Acceptance Testing: What Happens Before Final Handover

Purchasing medical equipment is only one part of bringing a new device or system into a healthcare facility. Before equipment is placed into routine clinical use, hospitals, clinics, laboratories, and government healthcare organizations typically need to verify that what arrived is what was ordered—and that it performs as expected. That verification process is commonly referred to as acceptance testing. Medical equipment acceptance testing helps confirm that equipment has been delivered in …
Aug 11th 2026 Truway Health
Building a Better Hospital Wound-Care Formulary

Building a Better Hospital Wound-Care Formulary

How health systems can standardize dressing selection, control inventory, support clinicians, and reduce unnecessary variation A hospital wound-care formulary should be more than a list of gauze, foams, hydrogels, alginates, and specialty dressings available from central supply. At its best, the formulary functions as a clinical and operational decision system—giving clinicians enough options to address different wound characteristics while preventing unnecessary SKU proliferation, inconsi …
Aug 8th 2026 Truway Health
Theranostics: Combining Diagnostic Imaging and Targeted Treatment

Theranostics: Combining Diagnostic Imaging and Targeted Treatment

Modern medicine is moving beyond treating every patient with the same standardized approach. One of the most promising examples is theranostics, a precision-medicine strategy that combines diagnostic testing with targeted treatment. The term blends two words: therapeutics and diagnostics. In nuclear medicine, theranostics typically uses two closely related radiopharmaceuticals. One is designed to locate and image a specific biological target, while the other delivers radiation directly to cells …
Aug 3rd 2026 Truway Health

TRUWAY HEALTH INSTAGRAM